Stock Analiz

BTSG vs CHE stock comparison

BrightSpring Health Services vs. Chemed · data as of November 13, 2026

BrightSpring Health Services (BTSG) has a market value of about $14.2B, Chemed (CHE) about $7.1B. Over their latest twelve months BrightSpring Health Services had revenue of $15.3B and Chemed $2.7B.

On our five checks Chemed scores higher: 2.4 out of 5 (weak) against 1.2 (weak).

By area, the stronger company is BrightSpring Health Services on future growth; Chemed on track record; Chemed on financial health; Chemed on shareholder returns.

Chemed is cheaper on earnings (P/E 26.3 vs. 50.5).

BrightSpring Health Services leads on 6 of the compared lines and Chemed on 15.

Side by side

BTSGCHE
Size and price
Market cap$14.2B$7.1B
Share price$71.21$548.20
Score
Overall score (of 5)1.22.4
Value00
Future growth40
Track record03
Financial health15
Shareholder returns14
Valuation
P/E (TTM)50.526.3
Forward P/E31.220.0
Price / free cash flow28.824.1
Price / sales0.92.7
EV / EBITDA23.317.1
PEG——
DCF value vs. price−9%−7%
Business
Revenue$15.3B$2.7B
Net income$410M$282M
Free cash flow$492M$295M
Net margin2.7%10.6%
Gross margin (5-yr avg.)14.2%35.0%
ROIC (5-yr avg.)6.9%23.7%
Growth
Revenue growth (1 yr)28.2%4.1%
Revenue growth (5 yrs, per year)—4.0%
EPS growth (5 yrs, per year)—-1.2%
Balance sheet and payouts
Net cash (cash minus debt)-$1.6B-$344M
Dividend yieldNone0.51%
Shareholder yield0.3%6.6%
Analysts
Upside to average target+17%+13%
Consensus ratingStrong buyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: BTSG TTM to September 30, 2026, CHE TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, BrightSpring Health Services or Chemed?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Chemed scores 2.4 out of 5 and BrightSpring Health Services 1.2; the table shows where each one is stronger.

Is BrightSpring Health Services cheaper than Chemed?

On trailing earnings, Chemed trades at a P/E of 26.3 and BrightSpring Health Services at 50.5, so Chemed is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which pays a higher dividend?

BrightSpring Health Services yields nothing (no dividend) and Chemed 0.51%.

Full BrightSpring Health Services analysis → Full Chemed analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.